Overview

Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of oral risperidone (Risperdal) to risperidone long-acting (Consta) in reducing alcohol use in persons diagnosed with schizophrenia or schizoaffective disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborator:
Janssen, LP
Treatments:
Ethanol
Risperidone